European Journal of Molecular & Clinical Medicine

Abstract

Oral cancer is the sixth most common cancer throughout the world and is a crucial issue in
regions where tobacco habits, in the form of chewing and/or smoking, with or without alcohol
intake, are common. Squamous cell carcinoma is the cause for 95% of oral cancers and is
associated with avoidable aetiological risk factors. The most successful means to enhance the
survival and reduce morbidity, damage, duration of treatment and hospital cost is the
detection of oral cancer at an early stage. It is essential to study marker levels in patients with
oral precancer who are at a high risk of developing oral cancer.
The present study was carried out to evaluate usefulness of serum Total Sialic Acid (TSA)
and serum Lipid-Bound Sialic Acid (LSA) as markers of oral submucous fibrosis and oral
cancer. Study consisted of 60 patients and 30 controls. There were 3 study groups, Group I
control, Group II OSMF, and Group III oral cancer consisting of 30 patients each. Serum of
all the patients in the control group and study groups were collected and stored at -20 oC until
analyzed. Levels of serum TSA and LSA were estimated spectrophotometrically. The results
also demonstrated that the assessment of TSA and LSA by simple, in-expensive and
reproducible methods can provide significant clinical information about the extent of
malignant disease and can differentiate between patients with oral precancer and oral cancer.